Stockreport

Here's Why We're Watching Monopar Therapeutics' (NASDAQ:MNPR) Cash Burn Situation [Yahoo! Finance]

Monopar Therapeutics Inc.  (MNPR) 
PDF For example, biotech and mining exploration companies often lose money for years before finding success with a new treatment or mineral discovery. But the harsh reality [Read more]